Fermenta Biotech Ltd. (FERMENTA) Share Price Within 2% of 52-Week High
- August 10, 2026
- Posted by: Harsh Piplani
- Category: News
Fermenta Biotech Ltd. Share Price is Rs 567 and the stock is trading within 2% of its 52-week high. The company’s market capitalisation stands at Rs 1,646.81 crore.
Fermenta Biotech Ltd. Share Price was Rs 567 at the time this Univest article was triggered on 10 August 2026 at 10:30:37 AM IST, placing the stock within 2% of its 52-week high. Fermenta Biotech Ltd. Share Price is therefore back in focus for investors tracking stocks that are trading close to their one-year peak, while the company’s market capitalisation stands at Rs 1,646.81 crore.
The key point in Fermenta Biotech Ltd. Share Price Today is not a claimed breakout or fresh high, but the verified fact that the Univest screener identified the stock as trading near its yearly high. That kind of proximity often attracts attention because it can reflect sustained investor interest, stronger relative positioning within a watchlist, or a broader rerating in progress. The supplied data confirms the price event, but it does not establish a company-specific catalyst.
For readers following Fermenta Biotech Ltd. Stock News, the useful question is whether the numbers around valuation, profitability, sector benchmarks and peer positioning support this attention. Univest data offers enough context to examine that without stretching beyond the verified figures.
Fermenta Biotech Ltd. Share Price Today: Within 2% of 52-Week High
| Metric | Value |
|---|---|
| LTP at 2% Qualification | Rs 567 |
| Market Capitalisation | Rs 1,646.81 crore |
| 52-Week High Position | Trading within 2% of its 52-week high |
Fermenta Biotech Ltd. (FERMENTA) traded at Rs 567. Reported volume was 7,756.
Fermenta Biotech Ltd. Share Price Today was Rs 567 at qualification, and Univest identifies the stock as trading within 2% of its 52-week high. Because the screener is designed specifically for this event, the setup matters for market participants who monitor stocks clustering near one-year peaks for signs of sustained strength, rerating interest or improving visibility.
In this case, the available data confirms the event-level last traded price of Rs 567, but it does not provide the exact 52-week high reference price in the supplied dataset. Even so, the qualification itself is clear: Fermenta Biotech Ltd. Share Price is close enough to its yearly high to enter a high-attention zone on the Univest platform.
That context matters because stocks trading near their 52-week high are often evaluated differently from stocks recovering from deep drawdowns. Investors usually shift from asking whether the price is stabilising to asking whether business quality, valuation and industry positioning can justify continued interest. Fermenta Biotech Ltd. Share Price is now in that category.
From a market-structure perspective, this kind of screen-based visibility can increase attention around current valuation multiples, earnings support and comparative positioning inside the Pharmaceuticals & Drugs space. That is why the next step is not speculation about direction, but a closer read of fundamentals, sector benchmarks and peers.
Fermenta Biotech Ltd. (FERMENTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,646.81 crore |
| P/E Ratio | 22.95x |
| P/B Ratio | 4.08x |
| ROE | 4.27% |
| ROCE | 7.5% |
| EPS | Rs 24.38 |
| Book Value Per Share | Rs 137.06 |
| Dividend Yield | 0.67% |
Fermenta Biotech Ltd. was valued at a P/E ratio of 22.95x, a P/B ratio of 4.08x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 4.27% and ROCE of 7.5%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 24.38, book value per share of Rs 137.06, dividend yield of 0.67%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 22.95x |
| Benchmark Median P/E | 18.11x |
| Benchmark Average P/E | 60.26x |
| Benchmark P/E Range | 0x to 3,417.8x |
| Company P/B Ratio | 4.08x |
| Benchmark Median P/B | 1.82x |
| Company ROE | 4.27% |
| Benchmark Median ROE | 9.93% |
| Company ROCE | 7.5% |
| Benchmark Median ROCE | 12.96% |
| Company Market Capitalisation | Rs 1,646.81 crore |
| Benchmark Median Market Cap | Rs 142.3 crore |
Fermenta Biotech Ltd. (FERMENTA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Fermenta Biotech Ltd. (FERMENTA) has a P/E ratio of 22.95x, which is above the benchmark median of 18.11x, a difference of +26.73%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Fermenta Biotech Ltd. (FERMENTA) has a ROE of 4.27%, which is below the benchmark median of 9.93%, a difference of -57%. Fermenta Biotech Ltd. (FERMENTA) has a ROCE of 7.5%, which is below the benchmark median of 12.96%, a difference of -42.13%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Jagsonpal Pharmaceuticals Ltd. | JAGSNPHARM | 1,533.19 | 33.71 | 6.11 | 15.7 | 19.43 |
| Amrutanjan Health Care Ltd. | AMRUTANJAN | 1,511.88 | 26.1 | 4.08 | 32.69 | 44 |
| Windlas Biotech Ltd. | WINDLAS | 1,823.52 | 27.44 | 3.55 | 12.87 | 14.88 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 1,986.64 | 47.97 | 1.35 | -0.78 | 8.31 |
| Indoco Remedies Ltd. | INDOCO | 2,045.45 | 363.31 | 2.04 | 12.85 | 15.67 |
Fermenta Biotech Ltd. (FERMENTA) has a P/E ratio of 22.95x compared with the displayed peer median of 33.71x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.27% compares with a peer median of 12.87% across the companies shown in the table. ROCE stood at 7.5% versus the displayed peer median of 15.67%, providing a capital-efficiency comparison. Fermenta Biotech Ltd. (FERMENTA) has a market capitalisation of Rs 1,646.81 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Fermenta Biotech Ltd.
- Fermenta Biotech Ltd. Share Price is Rs 567 and the stock is trading within 2% of its 52-week high, which naturally increases screen-based visibility.
- The company’s market capitalisation of Rs 1,646.81 crore is well above the same-industry median of Rs 142.3 crore and average of Rs 481.12 crore.
- Its P/E of 22.95 is above the industry median of 18.11 but below the industry average of 60.26, creating a balanced valuation discussion rather than an extreme one.
- P/B of 4.08 is above both the industry median of 1.82 and average of 2.89, showing the stock carries a richer book-value multiple.
- ROE of 4.27 and ROCE of 7.5 are below industry medians of 9.93 and 12.96, which adds caution to the valuation narrative.
- RSI stands at 52.41, a broadly neutral reading that suggests Fermenta Biotech Ltd. Share Price is being watched more for price proximity and valuation context than for an overheated momentum signal.
About Fermenta Biotech Ltd.
Fermenta Biotech Ltd. operates in the Healthcare sector and is classified under the Pharmaceuticals & Drugs industry in the supplied Univest dataset. Based on the verified classification available here, Fermenta Biotech Ltd. Share Price should be read in the context of listed pharmaceutical and healthcare businesses that are commonly compared on valuation, profitability and market-cap scale.
The current dataset does not provide product-level, segment-level or revenue-mix details, so the most reliable company context comes from its industry placement and listed-market metrics. For investors using Univest to track Fermenta Biotech Ltd. Stock News, the company presently stands out because it combines mid-sized market capitalisation within its industry group with a share price that is close to its one-year high.
Track Fermenta Biotech Ltd. Share Price on Univest
Use Fermenta Biotech Ltd. (FERMENTA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers tracking Fermenta Biotech Ltd. Share Price can use Univest to follow live price movement, 52-week levels, valuation ratios, profitability metrics, shareholding data when available, sector benchmarks and peer comparison in one place. Univest is especially useful when a stock enters event-based screens such as the near-52-week-high list, because it allows users to move from headline price action to deeper stock analysis.
For Fermenta Biotech Ltd. Share Price Today, that means monitoring how the stock’s premium-to-median valuation, below-median profitability and larger-than-average industry scale continue to interact over time on Univest.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Fermenta Biotech Ltd. Share Price today?
Ans. Fermenta Biotech Ltd. Share Price was Rs 567 when the Univest screener qualified the stock on 10 August 2026 at 10:30:37 AM IST. The same event confirmed that the stock was trading within 2% of its 52-week high.
Why is Fermenta Biotech Ltd. Share Price in focus?
Ans. Fermenta Biotech Ltd. Share Price is in focus because Univest identified the stock as trading within 2% of its 52-week high. That kind of proximity often draws attention to valuation, profitability, sector positioning and peer comparisons.
What is the market capitalisation of Fermenta Biotech Ltd.?
Ans. Fermenta Biotech Ltd. has a market capitalisation of Rs 1,646.81 crore. In the supplied same-industry benchmark of 139 companies, that is above the median market cap of Rs 142.3 crore and the average of Rs 481.12 crore.
Is Fermenta Biotech Ltd. Share Price expensive on valuation metrics?
Ans. Fermenta Biotech Ltd. Share Price trades at a P/E of 22.95 and P/B of 4.08. Its P/E is above the industry median of 18.11, while its P/B is above both the industry median of 1.82 and average of 2.89.
How profitable is Fermenta Biotech Ltd. compared with its industry?
Ans. Fermenta Biotech Ltd. reports ROE of 4.27 and ROCE of 7.5. Both figures are below the same-industry medians of 9.93 and 12.96, indicating profitability currently trails the central trend of its Pharmaceuticals & Drugs benchmark set.
What do EPS, book value and dividend yield show for Fermenta Biotech Ltd.?
Ans. Fermenta Biotech Ltd. reports EPS of Rs 24.38, book value per share of Rs 137.06 and dividend yield of 0.67. These figures show earnings per share, accounting net worth per share and the current historical payout relationship.
How does Fermenta Biotech Ltd. compare with selected peers?
Ans. Fermenta Biotech Ltd. has a lower P/E than Jagsonpal Pharmaceuticals, Amrutanjan Health Care, Windlas Biotech and Ind-Swift Laboratories, but its ROE and ROCE are also below several of these similarly sized peers in the Pharmaceuticals & Drugs industry.
Which sector and industry does Fermenta Biotech Ltd. belong to?
Ans. Fermenta Biotech Ltd. belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied benchmark compares it with 139 same-industry companies, while the broader Healthcare sector coverage includes 201 companies on Univest.
